Show simple item record

dc.contributor.authorWaddell, Ian D
dc.contributor.authorJames, Dominic I
dc.contributor.authorSmith, Kate M
dc.contributor.authorHolt, Sarah V
dc.contributor.authorActon, Ben
dc.contributor.authorFairweather, Emma E
dc.contributor.authorHamilton, Niall M
dc.contributor.authorHamilton, Nicola S
dc.contributor.authorHitchin, James R
dc.contributor.authorHuttom, Colin
dc.contributor.authorJordan, Allan M
dc.contributor.authorMcGonagle, Alison E
dc.contributor.authorSmall, Helen F
dc.contributor.authorStowell, Alexandra I J
dc.contributor.authorWaszkowycz, Bohdan
dc.contributor.authorOgilvie, Donald J
dc.date.accessioned2016-04-22T15:02:55Zen
dc.date.available2016-04-22T15:02:55Zen
dc.date.issued2015en
dc.identifier.citationPARG inhibition: development of novel compounds and a biomarker strategy to determine cell line sensitivity in breast cancer. 2015, 75(Aug Supp): Can Resen
dc.identifier.urihttp://hdl.handle.net/10541/606627en
dc.language.isoenen
dc.titlePARG inhibition: development of novel compounds and a biomarker strategy to determine cell line sensitivity in breast canceren
dc.typeMeetings and Proceedingsen
dc.contributor.departmentCRUK Manchester Institute, Manchesteren
dc.identifier.journalCancer Researchen


This item appears in the following Collection(s)

Show simple item record